PMID- 29742056 OWN - NLM STAT- MEDLINE DCOM- 20180731 LR - 20180731 IS - 0392-856X (Print) IS - 0392-856X (Linking) VI - 36 Suppl 110 IP - 1 DP - 2018 Jan-Feb TI - A dermatologic perspective on autoinflammatory diseases. PG - 32-38 AB - Autoinflammatory diseases (AIDs) encompass a heterogeneous group of disorders pathogenetically related to an abnormal activation of the innate immunity and clinically characterised by aseptic inflammation in the affected organs in the absence of high titer of circulating autoantibodies or autoreactive T cells. In classic monogenic AIDs, the skin is frequently involved with a wide range of cutaneous lesions. Monogenic AIDs result from different mutations in a single gene, which regulates the innate immunity. These mutations cause an uncontrolled activation of the inflammasome, leading to an overexpression of interleukin (IL)- 1beta. IL-1beta is the pivotal cytokine which is responsible for the exaggerated production of cytokines and chemokines that induce the recruitment of neutrophils, key cells in autoinflammation. Paradigmatic autoinflammatory forms are the cryopyrin-associated periodic syndromes (CAPS), whose skin involvement consists of urticarial lesions. Similar IL-1beta-mediated autoinflammatory pathomechanisms also occur in deficiency of IL-1 receptor antagonist (DIRA) and deficiency of IL-36 receptor antagonist (DITRA), whose cutaneous appearance is characterised by pustular lesions, as well as in pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome. Pyoderma gangrenosum, which is the cutaneous hallmark of the PAPA syndrome, is a prototypic neutrophil-mediated skin disease, manifesting as single or multiple ulcers with undermined, raised erythematous to violaceous borders. This review is focused on the CAPS, DIRA/DITRA and PAPA syndromes with emphasis on their cutaneous manifestations, as well as their histology and pathophysiology. FAU - Marzano, Angelo Valerio AU - Marzano AV AD - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universita degli Studi di Milano, Unita Operativa di Dermatologia, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy. angelo.marzano@unimi.it. FAU - Damiani, Giovanni AU - Damiani G AD - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universita degli Studi di Milano, Unita Operativa di Dermatologia, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy. FAU - Genovese, Giovanni AU - Genovese G AD - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universita degli Studi di Milano, Unita Operativa di Dermatologia, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy. FAU - Gattorno, Marco AU - Gattorno M AD - UOC Pediatria 2, G. Gaslini Institute, Genova, Italy. LA - eng PT - Journal Article PT - Review DEP - 20180503 PL - Italy TA - Clin Exp Rheumatol JT - Clinical and experimental rheumatology JID - 8308521 RN - 0 (Cytokines) RN - 0 (Inflammasomes) RN - 0 (Interleukin 1 Receptor Antagonist Protein) RN - Deficiency of interleukin-1 receptor antagonist RN - Pyogenic arthritis, pyoderma gangrenosum, and acne SB - IM MH - Acne Vulgaris/complications/immunology/pathology MH - Arthritis, Infectious/complications/immunology/pathology MH - Cryopyrin-Associated Periodic Syndromes/complications/immunology/pathology MH - Cytokines/*immunology MH - Hereditary Autoinflammatory Diseases/complications/*immunology/pathology MH - Humans MH - Immunity, Innate/*immunology MH - Inflammasomes/*immunology MH - Interleukin 1 Receptor Antagonist Protein/immunology MH - Pyoderma Gangrenosum/complications/immunology/pathology MH - Skin Diseases/etiology/*immunology/pathology EDAT- 2018/05/10 06:00 MHDA- 2018/08/01 06:00 CRDT- 2018/05/10 06:00 PHST- 2017/11/27 00:00 [received] PHST- 2017/12/07 00:00 [accepted] PHST- 2018/05/10 06:00 [entrez] PHST- 2018/05/10 06:00 [pubmed] PHST- 2018/08/01 06:00 [medline] AID - 12471 [pii] PST - ppublish SO - Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):32-38. Epub 2018 May 3.